The Canadian Patent Office (CIPO) has advised that as of January 14, 2025, it had granted patents for which final fees were processed in the old system. CIPO has started to process applications where final fees were paid in the Next Generation Patents (NGP) system, and has started granting these patents. The Canadian Patent Database will indicate the status of patents as “Pre-grant”, which means that the final fee payment has been processed and determined compliant.
CIPO is temporarily publishing a List of “Pre-grant” applications that indicates a predicted grant date, with a new file posted weekly normally on Thursday. CIPO has warned that this is not a guaranteed grant date, but if not granted on the predicted date, the patent should be granted the following week.
The weekly list of granted and issued patents is also posted by CIPO, normally posted on Tuesdays.
The preceding is intended as a timely update on Canadian intellectual property and life sciences regulatory law. The content is informational only and does not constitute legal or professional advice. To obtain such advice, please communicate with our offices directly.
Related Publications & Articles
-
Canada’s Drug Agency releases 2025 Watch List highlighting AI technologies in health care
On March 25, 2025, Canada’s Drug Agency published its annual Watch List, which identifies technologies with the most potential to transform health systems and shape the future of health care in Canada...Read More -
Health Canada publishes Guide to the precision regulating authorities under the Food and Drugs Act
In March 2025, Health Canada published a Guide to the precision regulating authorities under the Food and Drugs Act.Read More -
Basic style or original work? Social media influencers and the line between style and copyright infringement
How social media influencer aesthetics intersect with Canadian copyright law
The intellectual property issues surrounding social media influencer aesthetics have recently received attention in the United States after one influencer asserted a variety of claims against another ...Read More